The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate deficiency, a rare disorder.

The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same ...

Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...

By Ahmed Aboulenein and Julie Steenhuysen WASHINGTON, March 10 (Reuters) - The U.S. FDA on Tuesday approved leucovorin, a ...

Thyroid disorders, polycystic ovary syndrome (PCOS), autoimmune diseases, osteoporosis, and iron deficiency anaemia are some of the health conditions that affect women more than men.

The FDA has approved Wellcovorin (leucovorin) for cerebral folate deficiency (CFD-FOLR1), the first-ever treatment for the rare genetic neurological condition.

Adults with a deficiency of vitamin D are at increased risk for developing dry eye disease than those without low levels of the nutrient, a study finds.

The Food and Drug Administration approved leucovorin to treat a neurological disorder with some symptoms similar to autism.

Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...

It's a major step back from statements made at a White House news conference in September, when President Donald Trump and ...

In September, Trump and the FDA commissioner announced the drug was under review to benefit patients with autism. The FDA didn't find evidence of that.

Washington — The U.S. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called cerebral folate deficiency, but not for children with the much ...